Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy: A Randomized, Double-Masked, Cross-Over Study
Diabetes Care - United States
doi 10.2337/diacare.28.9.2106
Full Text
Open PDFAbstract
Available in full text
Date
August 25, 2005
Authors
Publisher
American Diabetes Association